Bioton valued at over zł.2 billion but analysts cast doubts

"The company has strong growth potential, but after looking at its results one can consider whether it should be so high. It seems that most of the investors in the company have a speculative attitude," said Ewa Radkowska from ING Investment Management. Other analysts believe that the potential benefits of the contract with SciGen are too distant to be seriously discounted at present. Bioton's capitalization currently zł.562 million more than the capitalization of Prokom, which owns Bioton. Ryszard Krauze, president of the supervisory board and indirectly the largest shareholder of Bioton, announced shortly after the IPO of the company that it will soon become the main engine of his group. (Parkiet; 22-23 October; p. 2) M.M.